Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$195M |
| 2 |
Comcast
CMCSA
|
+$164M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$157M |
| 4 |
AB InBev
BUD
|
+$151M |
| 5 |
FDC
First Data Corporation
FDC
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$414M |
| 2 |
AABA
Altaba Inc
AABA
|
+$290M |
| 3 |
Sherwin-Williams
SHW
|
+$229M |
| 4 |
Danaher
DHR
|
+$215M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Energy | 9.87% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
Walt Disney
DIS
$186B
| $73.8M | 0.32% |
686,400
-4,035,500
| -85% | -$416M |
|
|
ARRY
77
DELISTED
Array Biopharma Inc
ARRY
| $73.1M | 0.32% |
5,712,626
-3,296,373
| -37% | -$37.5M |
|
78
Capital One
COF
$134B
| $73M | 0.32% |
733,300
-913,991
| -55% | -$83.4M |
|
79
AutoZone
AZO
$48.3B
| $73M | 0.32% |
+102,645
| New | +$65.6M |
|
80
CALL
McDonald's
MCD
$192B
| $72.3M | 0.31% |
420,000
+310,000
| +282% | +$52.1M |
|
81
Acadia Pharmaceuticals
ACAD
$5.08B
| $72.1M | 0.31% |
2,396,098
+1,670,898
| +230% | +$53.4M |
|
82
CALL
Gilead Sciences
GILD
$181B
| $71.6M | 0.31% |
+1,000,000
| New | +$75.9M |
|
|
ADMS
83
DELISTED
Adamas Pharmaceuticals
ADMS
| $71.5M | 0.31% |
2,109,455
+1,259,290
| +148% | +$35.2M |
|
|
DVAX
84
DELISTED
Dynavax Technologies
DVAX
| $71.2M | 0.31% |
3,808,142
+2,697,514
| +243% | +$54.2M |
|
|
FMSA
85
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $70.4M | 0.3% |
13,468,364
-3,722,461
| -22% | -$17.5M |
|
86
Trane Technologies
TT
$99.8B
| $69.6M | 0.3% |
+779,888
| New | +$68.7M |
|
|
AVXS
87
DELISTED
AveXis, Inc. Common Stock
AVXS
| $67.8M | 0.29% |
612,611
-31,026
| -5% | -$3.11M |
|
|
XEC
88
DELISTED
CIMAREX ENERGY CO
XEC
| $67.6M | 0.29% |
553,723
+303,723
| +121% | +$35.4M |
|
|
BERY
89
DELISTED
Berry Global Group, Inc.
BERY
| $66.4M | 0.29% |
1,232,115
+749,688
| +155% | +$40.8M |
|
90
Green Plains
GPRE
$1.14B
| $65.5M | 0.28% |
3,887,860
+754,437
| +24% | +$13.3M |
|
91
RTX Corp
RTX
$283B
| $64.9M | 0.28% |
808,660
-885,641
| -52% | -$67.2M |
|
92
CALL
Charter Communications
CHTR
$17.9B
| $64.2M | 0.28% |
191,000
-9,600
| -5% | -$3.26M |
|
93
CALL
Bunge Global
BG
$21.7B
| $63.9M | 0.28% |
+952,500
| New | +$64.7M |
|
94
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $63.7M | 0.27% |
750,000
+250,000
| +50% | +$20.9M |
|
95
Mercado Libre
MELI
$97.5B
| $63.6M | 0.27% |
202,230
+94,530
| +88% | +$25.6M |
|
96
Colgate-Palmolive
CL
$72.6B
| $62.8M | 0.27% |
832,008
+807,108
| +3,241% | +$58.9M |
|
97
T-Mobile US
TMUS
$196B
| $62.4M | 0.27% |
982,110
+871,190
| +785% | +$53.2M |
|
98
Zimmer Biomet
ZBH
$19.3B
| $61.9M | 0.27% |
528,067
-190,770
| -27% | -$21.6M |
|
99
Steel Dynamics
STLD
$32.8B
| $61.4M | 0.27% |
1,423,943
+1,226,245
| +620% | +$47.2M |
|
100
CALL
General Dynamics
GD
$104B
| $61M | 0.26% |
+300,000
| New | +$61.3M |
|
Similar funds
Steven Cohen's Q4 2017 Portfolio in Review
As of Q4 2017, Steven Cohen held 1,233 positions worth $23.2B, up 3.4% from $22.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steven Cohen's Q4 2017 filing shows 387 new, 243 increased, 233 reduced and 356 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 481,354 shares worth $181M. The largest sale was Time Warner Inc, an estimated $414M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- Steven Cohen's largest Q4 2017 buy was Regeneron Pharmaceuticals: 481,354 shares worth $181M.
- Steven Cohen added most to Comcast in Q4 2017, an estimated $164M increase.
- Steven Cohen's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $414M.
- Steven Cohen fully exited Sherwin-Williams in Q4 2017, selling an estimated $229M.
- Steven Cohen's ten largest holdings make up 13% of its $23.2B portfolio in Q4 2017.
- Steven Cohen opened 387 new positions and closed 356 in Q4 2017.
- Steven Cohen's portfolio value rose 3.4% quarter-over-quarter to $23.2B.
Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.